Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
ClinicalTrials.gov study NCT07148128. IPD Sharing: NO. Countries: 3. Publications: 0.
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
ClinicalTrials.gov study NCT05554367. IPD Sharing: YES. Countries: 2. Publications: 0.
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
ClinicalTrials.gov study NCT07213570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
ClinicalTrials.gov study NCT03878719. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
ClinicalTrials.gov study NCT03567642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure
ClinicalTrials.gov study NCT06786208. IPD Sharing: NO. Countries: 1. Publications: 0.
Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
ClinicalTrials.gov study NCT02064491. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations
ClinicalTrials.gov study NCT07178717. IPD Sharing: NO. Countries: 1. Publications: 0.
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
ClinicalTrials.gov study NCT05580562. IPD Sharing: Not stated. Countries: 18. Publications: 0.
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
ClinicalTrials.gov study NCT04643847. IPD Sharing: NO. Countries: 1. Publications: 0.
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
ClinicalTrials.gov study NCT04575415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)
ClinicalTrials.gov study NCT05546905. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
ClinicalTrials.gov study NCT02619435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
ClinicalTrials.gov study NCT05851378. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity
ClinicalTrials.gov study NCT02911233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07028489. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression
ClinicalTrials.gov study NCT02431169. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC
ClinicalTrials.gov study NCT02109653. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Whole Genomic Landscape of Advanced EGFR-mutant NSCLC
ClinicalTrials.gov study NCT03969823. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
ClinicalTrials.gov study NCT06346067. IPD Sharing: NO. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.